1. Complex renal cysts associated with crizotinib treatment. (10th March 2015) Authors: Schnell, Patrick; Bartlett, Cynthia H.; Solomon, Benjamin J.; Tassell, Vanessa; Shaw, Alice T.; de Pas, Tommaso; Lee, Soo‐Hyun; Lee, Geon Kook; Tanaka, Kaoru; Tan, Weiwei; Tang, Yiyun; Wilner, Keith D.; Safferman, Allan; Han, Ji‐Youn Journal: Cancer medicine Issue: Volume 4:Number 6(2015:Jun.) Page Start: 887 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non‐small cell lung cancer (NSCLC) in Europe. Issue 2 (31st March 2020) Authors: Huang, Kui; Madison, Terri; Wehler, Beatrice; Tiseo, Marcello; Wilner, Keith D.; Mo, Jingping Journal: Pharmacology research & perspectives Issue: Volume 8:Issue 2(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Factors associated with sinus bradycardia during crizotinib treatment: a retrospective analysis of two large‐scale multinational trials (PROFILE 1005 and 1007). (28th January 2016) Authors: Ou, Sai‐Hong Ignatius; Tang, Yiyun; Polli, Anna; Wilner, Keith D.; Schnell, Patrick Journal: Cancer medicine Issue: Volume 5:Number 4(2016:Apr.) Page Start: 617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ophthalmological assessment of crizotinib in advanced non-small-cell lung cancer. (July 2020) Authors: Solomon, Benjamin J.; Kim, Elizabeth E.; Winter, Maria; Monti, Katherine; Tang, Yiyun; Wilner, Keith D.; Wang, Sherry; Ou, Sai-Hong Ignatius Journal: Lung cancer Issue: Volume 145(2020) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post‐authorization safety cohort study conducted in Europe and in the United States. Issue 6 (24th January 2021) Authors: Ehrenstein, Vera; Huang, Kui; Kahlert, Johnny; Bahmanyar, Shahram; Karlsson, Pär; Löfling, Lukas; Nunes, Anthony P.; Enger, Cheryl; Bezemer, Irene D.; Kuiper, Josephina G.; Hoti, Fabian; Juuti, Rosa; Korhonen, Pasi; Mo, Jingping; Schachterle, Stephen E.; Wilner, Keith D.; Rørth, Mikael; Sørensen,... Journal: Pharmacoepidemiology and drug safety Issue: Volume 30:Issue 6(2021) Page Start: 758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer. Issue 3 (March 2018) Authors: Durairaj, Chandrasekar; Ruiz-Garcia, Ana; Gauthier, Eric R.; Huang, Xin; Lu, Dongrui R.; Hoffman, Justin T.; Finn, Richard S.; Joy, Anil A.; Ettl, Johannes; Rugo, Hope S.; Zheng, Jenny; Wilner, Keith D.; Wang, Diane D. Journal: Anti-cancer drugs Issue: Volume 29:Issue 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050). (April 2021) Authors: Cheng, Ying; Mok, Tony S.; Zhou, Xiangdong; Lu, Shun; Zhou, Qing; Zhou, Jianying; Du, Yingying; Yu, Ping; Liu, Xiaoqing; Hu, Chengping; Lu, You; Zhang, Yiping; Lee, Ki Hyeong; Nakagawa, Kazuhiko; Linke, Rolf; Wong, Chew Hooi; Tang, Yiyun; Zhu, Fanfan; Wilner, Keith D.; Wu, Yi-Long Journal: Lung cancer Issue: Volume 154(2021) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗